{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:45:04Z","timestamp":1772840704406,"version":"3.50.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.autrev.2011.05.015","type":"journal-article","created":{"date-parts":[[2011,5,22]],"date-time":"2011-05-22T17:11:06Z","timestamp":1306084266000},"page":"212-218","source":"Crossref","is-referenced-by-count":61,"title":["Immunization in the adult immunocompromised host"],"prefix":"10.1016","volume":"11","author":[{"given":"Micha","family":"L\u00f6bermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Bor\u0161o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inken","family":"Hilgendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Fritzsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe K.","family":"Zettl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil C.","family":"Reisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.autrev.2011.05.015_bb0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom","volume":"93","author":"van Staa","year":"2000","journal-title":"QJM"},{"issue":"4 Pt 2","key":"10.1016\/j.autrev.2011.05.015_bb0010","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1600-6143.2009.02564.x","article-title":"Trends in organ donation and transplantation in the United States, 1998\u20132007","volume":"9","author":"Wolfe","year":"2009","journal-title":"Am J Transplant"},{"issue":"978","key":"10.1016\/j.autrev.2011.05.015_bb0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/pgmj.2006.052688","article-title":"Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution","volume":"83","author":"Kuek","year":"2007","journal-title":"Postgrad Med J"},{"issue":"10","key":"10.1016\/j.autrev.2011.05.015_bb0020","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/rheumatology\/keq183","article-title":"Vaccinations in patients with immune-mediated inflammatory diseases","volume":"49","author":"Rahier","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2011.05.015_bb0025","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"2","key":"10.1016\/j.autrev.2011.05.015_bb0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/rheumatology\/kel236","article-title":"Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients","volume":"46","author":"Salliot","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2011.05.015_bb0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/08830181003746304","article-title":"Could autoimmunity be induced by vaccination?","volume":"29","author":"Salemi","year":"2010","journal-title":"Int Rev Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2011.05.015_bb0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/08830185.2010.483028","article-title":"Are anti-infectious vaccinations safe and effective in patients with autoimmunity?","volume":"29","author":"Salemi","year":"2010","journal-title":"Int Rev Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2011.05.015_bb0045","first-page":"181","article-title":"Vaccination and multiple sclerosis","volume":"81","author":"Loebermann","year":"2010","journal-title":"Nervenarzt"},{"issue":"10","key":"10.1016\/j.autrev.2011.05.015_bb0050","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1136\/ard.2010.129908","article-title":"Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study","volume":"69","author":"Bengtsson","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2011.05.015_bb0055","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/0961203306069355","article-title":"Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety","volume":"15","author":"O'Neill","year":"2006","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.autrev.2011.05.015_bb0060","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.autrev.2006.09.012","article-title":"Influenza vaccination in systemic lupus erythematosus: safe and protective?","volume":"6","author":"Holvast","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.25033","article-title":"Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab","volume":"62","author":"van Assen","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2011.05.015_bb0070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/0961203307078225","article-title":"Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus","volume":"16","author":"Kuruma","year":"2007","journal-title":"Lupus"},{"issue":"245","key":"10.1016\/j.autrev.2011.05.015_bb0075","first-page":"798","article-title":"Immunization guidelines regarding patients with a chronic disease","volume":"6","author":"Aubert","year":"2010","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.autrev.2011.05.015_bb0080","first-page":"1","article-title":"Advisory Committee on Immunization Practices Centers for Disease C, Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Kroger","year":"2006"},{"key":"10.1016\/j.autrev.2011.05.015_bb0085","doi-asserted-by":"crossref","unstructured":"Rubbert-Roth A. [Vaccination in adult rheumatology]. Z Rheumatol 2007 Mar;66(2):102-10.","DOI":"10.1007\/s00393-007-0144-x"},{"key":"10.1016\/j.autrev.2011.05.015_bb0090","first-page":"353","article-title":"Hinweise zu Impfungen f\u00fcr Patienten mit Immundefizienz","volume":"39","author":"STIKO","year":"2005","journal-title":"Epidemiol Bull"},{"key":"10.1016\/j.autrev.2011.05.015_bb0095","unstructured":"Zimmerman RK, Middleton DB. Vaccines for persons at high risk, 2007. J Fam Pract 2007 Feb;56(2 Suppl Vaccines):S104-S112."},{"issue":"4","key":"10.1016\/j.autrev.2011.05.015_bb0100","first-page":"289","article-title":"Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma","volume":"70","author":"Lahood","year":"1993","journal-title":"Ann Allergy"},{"issue":"3","key":"10.1016\/j.autrev.2011.05.015_bb0105","first-page":"498","article-title":"Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients","volume":"34","author":"Wallin","year":"2009","journal-title":"Acta Reumatol Port"},{"issue":"59","key":"10.1016\/j.autrev.2011.05.015_bb0110","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"30","author":"Staples","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"10","key":"10.1016\/j.autrev.2011.05.015_bb0115","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/598193","article-title":"Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients","volume":"48","author":"Evison","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ndt\/13.1.160","article-title":"Suppression of the humoral immune response by mycophenolate mofetil","volume":"13","author":"Smith","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.autrev.2011.05.015_bb0125","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1159\/000119742","article-title":"Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial","volume":"28","author":"Keshtkar-Jahromi","year":"2008","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0130","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1111\/j.1399-0012.2009.01095.x","article-title":"Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs","volume":"24","author":"Salles","year":"2010","journal-title":"Clin Transplant"},{"issue":"8","key":"10.1016\/j.autrev.2011.05.015_bb0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","article-title":"Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses","volume":"9","author":"Kunisaki","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.25034","article-title":"Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial","volume":"62","author":"Bingham","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2011.05.015_bb0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00007890-199707270-00010","article-title":"Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients","volume":"64","author":"Enke","year":"1997","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2008.09.023","article-title":"Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study","volume":"54","author":"Birdwell","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2011.05.015_bb0155","unstructured":"WHO. Priority interventions: HIV\/AIDS prevention, treatment and care in the health sector \u2014 2010. Volume 2.0 Geneva: WHO Press, 2010."},{"issue":"12","key":"10.1016\/j.autrev.2011.05.015_bb0160","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2893.2009.01249.x","article-title":"Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996\u20132007","volume":"17","author":"Spradling","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.autrev.2011.05.015_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2334-10-53","article-title":"Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India","volume":"10","author":"Gupta","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.autrev.2011.05.015_bb0170","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1258\/ijsa.2009.009126","article-title":"Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations","volume":"20","author":"Kim","year":"2009","journal-title":"Int J STD AIDS"},{"issue":"3","key":"10.1016\/j.autrev.2011.05.015_bb0175","first-page":"157","article-title":"Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions","volume":"11","author":"van den Berg","year":"2009","journal-title":"AIDS Rev"},{"issue":"34","key":"10.1016\/j.autrev.2011.05.015_bb0180","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1016\/j.vaccine.2009.04.016","article-title":"Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count","volume":"27","author":"Landrum","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2011.05.015_bb0185","series-title":"Guidelines: clinical management and treatment of HIV infected adults in Europe","author":"EACS","year":"2009"},{"issue":"5","key":"10.1016\/j.autrev.2011.05.015_bb0190","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/605292","article-title":"Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America","volume":"49","author":"Aberg","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2011.05.015_bb0195","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/clinids\/21.Supplement_1.S77","article-title":"Preventing bacterial respiratory tract infections among persons infected with human immunodeficiency virus","volume":"21","author":"Keller","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.autrev.2011.05.015_bb0200","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/319218","article-title":"Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination","volume":"32","author":"Dworkin","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.autrev.2011.05.015_bb0205","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/infdis\/162.5.1012","article-title":"The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents","volume":"162","author":"Redd","year":"1990","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.autrev.2011.05.015_bb0210","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1086\/430356","article-title":"Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995\u20132000","volume":"191","author":"Heffernan","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2011.05.015_bb0215","unstructured":"CDC. Recommendations of the Immunization Practices Advisory Committee: pneumococcal polysaccharide vaccine. MMWR Morb Mortal Wkly Rep 1989 Feb 10;38(5):64\u20138, 73\u20136."},{"issue":"10","key":"10.1016\/j.autrev.2011.05.015_bb0220","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1468-1293.2008.00637.x","article-title":"British HIV Association guidelines for immunization of HIV-infected adults 2008","volume":"9","author":"Geretti","year":"2008","journal-title":"HIV Med"},{"issue":"9221","key":"10.1016\/j.autrev.2011.05.015_bb0225","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(00)02377-1","article-title":"23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial","volume":"355","author":"French","year":"2000","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.autrev.2011.05.015_bb0230","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"French","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.autrev.2011.05.015_bb0235","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7326\/0003-4819-138-6-200303180-00008","article-title":"High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse","volume":"138","author":"Piketty","year":"2003","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.autrev.2011.05.015_bb0240","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1086\/656320","article-title":"Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men","volume":"202","author":"Wilkin","year":"2010","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.autrev.2011.05.015_bb0245","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2010.03.038","article-title":"The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: a meta-analysis of current literature","volume":"28","author":"Alavian","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.autrev.2011.05.015_bb0250","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/BF00870139","article-title":"The immune response to influenza vaccination in diabetic patients","volume":"29","author":"Pozzilli","year":"1986","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.autrev.2011.05.015_bb0255","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S095026889700825X","article-title":"Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes","volume":"119","author":"Colquhoun","year":"1997","journal-title":"Epidemiol Infect"},{"issue":"8","key":"10.1016\/j.autrev.2011.05.015_bb0260","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2337\/dc05-2517","article-title":"Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients","volume":"29","author":"Looijmans-Van den Akker","year":"2006","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.autrev.2011.05.015_bb0265","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0272-6386(95)90491-3","article-title":"Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure","volume":"26","author":"Girndt","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.autrev.2011.05.015_bb0270","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1681\/ASN.2007090971","article-title":"Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients","volume":"19","author":"Litjens","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.autrev.2011.05.015_bb0275","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1440-1797.2009.01268.x","article-title":"Review article: hepatitis B and dialysis","volume":"15","author":"Edey","year":"2010","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1016\/j.autrev.2011.05.015_bb0280","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5414\/CNP68228","article-title":"Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination","volume":"68","author":"Tsouchnikas","year":"2007","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bpg.2006.07.004","article-title":"Prevention and treatment of infections in patients with cirrhosis","volume":"21","author":"Ghassemi","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0290","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2008-1040319","article-title":"Bacterial infections, sepsis, and multiorgan failure in cirrhosis","volume":"28","author":"Tandon","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"25\u201326","key":"10.1016\/j.autrev.2011.05.015_bb0295","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1016\/j.vaccine.2009.01.077","article-title":"Influenza vaccination in patients with cirrhosis and in liver transplant recipients","volume":"27","author":"Gaeta","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.autrev.2011.05.015_bb0300","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcv.2009.05.006","article-title":"Why actively promote vaccination in patients with cirrhosis?","volume":"46","author":"Loulergue","year":"2009","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0305","first-page":"1","article-title":"Recommended adult immunization schedule\u2014United States, 2010","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.autrev.2011.05.015_bb0310","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri2508","article-title":"B-cell responses to vaccination at the extremes of age","volume":"9","author":"Siegrist","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2011.05.015_bb0315","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.jcpa.2009.10.002","article-title":"Fading immune protection in old age: vaccination in the elderly","volume":"142","author":"Grubeck-Loebenstein","year":"2010","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.autrev.2011.05.015_bb0320","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-4933-7-7","article-title":"Factors that may impact on immunosenescence: an appraisal","volume":"7","author":"Ongradi","year":"2010","journal-title":"Immun Ageing"},{"issue":"39","key":"10.1016\/j.autrev.2011.05.015_bb0325","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1016\/j.vaccine.2009.06.080","article-title":"High tetanus and diphtheria antitoxin concentrations in Finnish adults\u2014time for new booster recommendations?","volume":"27","author":"Olander","year":"2009","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.autrev.2011.05.015_bb0330","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1016\/j.vaccine.2006.04.016","article-title":"Hepatitis A\/B vaccination of adults over 40years old: comparison of three vaccine regimens and effect of influencing factors","volume":"24","author":"Van der Wielen","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.autrev.2011.05.015_bb0335","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.autrev.2011.05.015_bb0340","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2165\/00002512-200724100-00001","article-title":"Advances in pneumococcal vaccines: what are the advantages for the elderly?","volume":"24","author":"Vila-Corcoles","year":"2007","journal-title":"Drugs Aging"},{"issue":"10","key":"10.1016\/j.autrev.2011.05.015_bb0345","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.vaccine.2008.11.098","article-title":"Immunological responses to pneumococcal vaccine in frail older people","volume":"27","author":"Ridda","year":"2009","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.autrev.2011.05.015_bb0350","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.vaccine.2010.03.024","article-title":"Decreased antibody titers and booster responses in tick-borne encephalitis vaccines aged 50\u201390years","volume":"28","author":"Weinberger","year":"2010","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.autrev.2011.05.015_bb0355","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.autrev.2011.05.015_bb0360","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/10489140-000000000-00000","article-title":"Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults","volume":"27","author":"Sanford","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.autrev.2011.05.015_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v36i00a06","article-title":"Statement on the recommended use of herpes zoster vaccine","volume":"36","author":"NACI","year":"2010","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.autrev.2011.05.015_bb0370","first-page":"279","article-title":"Empfehlungen der Standigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: Juli 2010","volume":"30","author":"STIKO","year":"2010","journal-title":"Epidemiol Bull"},{"key":"10.1016\/j.autrev.2011.05.015_bb0375","series-title":"Common variable immune deficiency overview","author":"Scharenberg","year":"1993"},{"issue":"2","key":"10.1016\/j.autrev.2011.05.015_bb0380","first-page":"45","article-title":"Prevention of infections in hyposplenic and asplenic patients: an update","volume":"62","author":"Melles","year":"2004","journal-title":"Neth J Med"},{"issue":"7\u20138","key":"10.1016\/j.autrev.2011.05.015_bb0385","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1345\/aph.1A277","article-title":"Immunization recommendations for adults with cancer","volume":"36","author":"Arrowood","year":"2002","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0390","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clon.2004.07.010","article-title":"Recommendations for influenza and pneumococcal vaccinations in people receiving chemotherapy","volume":"17","author":"Melcher","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0395","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2141.2001.02882.x","article-title":"Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia","volume":"114","author":"Sinisalo","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0400","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.vaccine.2007.10.053","article-title":"Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia","volume":"26","author":"Sinisalo","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0405","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beha.2009.12.004","article-title":"Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches","volume":"23","author":"Morrison","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.autrev.2011.05.015_bb0410","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/bmb\/ldn034","article-title":"The immunodeficiency of chronic lymphocytic leukaemia","volume":"87","author":"Hamblin","year":"2008","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0415","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3960\/jslrt.49.9","article-title":"Attenuated antibody reaction for the primary antigen but not for the recall antigen of influenza vaccination in patients with non-Hodgkin B-cell lymphoma after the administration of rituximab-CHOP","volume":"49","author":"Takata","year":"2009","journal-title":"J Clin Exp Hematop"},{"issue":"4","key":"10.1016\/j.autrev.2011.05.015_bb0420","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3121\/cmr.3.4.214","article-title":"Efficacy of the influenza vaccine in patients with malignant lymphoma","volume":"3","author":"Mazza","year":"2005","journal-title":"Clin Med Res"},{"issue":"10","key":"10.1016\/j.autrev.2011.05.015_bb0425","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1086\/644734","article-title":"Vaccination of solid-organ transplantation candidates","volume":"49","author":"Chow","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.autrev.2011.05.015_bb0430","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/CMR.16.3.357-364.2003","article-title":"Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols","volume":"16","author":"Duchini","year":"2003","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.autrev.2011.05.015_bb0435","first-page":"1295","article-title":"Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B","volume":"140","author":"Phillips","year":"1992","journal-title":"Am J Pathol"},{"issue":"Supplement_2","key":"10.1016\/j.autrev.2011.05.015_bb0440","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.2215\/CJN.02900707","article-title":"Viral infection after renal transplantation: surveillance and management","volume":"3","author":"Weikert","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.autrev.2011.05.015_bb0445","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.transproceed.2005.05.032","article-title":"Vaccinations for adult solid organ transplant recipient: current recommendations","volume":"37","author":"Ballout","year":"2005","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.autrev.2011.05.015_bb0450","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.trre.2008.07.001","article-title":"Vaccination of the solid organ transplant recipient","volume":"22","author":"Sester","year":"2008","journal-title":"Transplant Rev (Orlando)"},{"issue":"7\u20138","key":"10.1016\/j.autrev.2011.05.015_bb0455","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0264-410X(98)00272-2","article-title":"Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients","volume":"17","author":"Dengler","year":"1999","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.autrev.2011.05.015_bb0460","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.idc.2010.01.010","article-title":"Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology","volume":"24","author":"Wingard","year":"2010","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.autrev.2011.05.015_bb0465","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/146532401753156403","article-title":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation","volume":"3","author":"CDC","year":"2001","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1016\/j.autrev.2011.05.015_bb0470","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl. 6","key":"10.1016\/j.autrev.2011.05.015_bb0475","first-page":"28","article-title":"Vaccination of haematopoietic stem cell transplant recipients: report from the International Consensus Conference on Clinical Practice in chronic GVHD","volume":"33","author":"Hilgendorf","year":"2010","journal-title":"Onkologie"},{"issue":"16","key":"10.1016\/j.autrev.2011.05.015_bb0480","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2011.02.018","article-title":"Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the International Consensus Conference on Clinical Practice in chronic GVHD","volume":"29","author":"Hilgendorf","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.autrev.2011.05.015_bb0485","first-page":"961","article-title":"A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT","volume":"18","author":"Parkkali","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.autrev.2011.05.015_bb0490","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2249.1992.tb06480.x","article-title":"Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation","volume":"88","author":"Lortan","year":"1992","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2011.05.015_bb0495","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00366446","article-title":"Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction","volume":"1","author":"Hammarstrom","year":"1993","journal-title":"Support Care Cancer"},{"issue":"15","key":"10.1016\/j.autrev.2011.05.015_bb0500","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.vaccine.2010.01.025","article-title":"Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial","volume":"28","author":"Cordonnier","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.autrev.2011.05.015_bb0505","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood-2006-06-032284","article-title":"Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation","volume":"109","author":"Meisel","year":"2007","journal-title":"Blood"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T02:11:42Z","timestamp":1560219102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1568997211001170"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.05.015","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}